- Home
- FUSB vs XBIT Comparison
FUSB vs XBIT Comparison
Compare FUSB & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FUSB | XBIT |
|---|---|---|
| Founded | 1952 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Pharmaceuticals and Biotechnology |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 86.5M | 71.6M |
| IPO Year | 1995 | 2015 |
Fundamental Metrics
Financial Performance| Metric | FUSB | XBIT |
|---|---|---|
| Price | $14.80 | $2.35 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 7.2K | ★ 24.8K |
| Earning Date | 04-29-2026 | 01-01-0001 |
| Dividend Yield | ★ 1.86% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.64 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $23.50 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.47 | $2.09 |
| 52 Week High | $15.99 | $3.62 |
Technical Indicators
Market Signals| Indicator | FUSB | XBIT |
|---|---|---|
| Relative Strength Index (RSI) | 45.86 | 46.55 |
| Support Level | $12.26 | $2.32 |
| Resistance Level | $14.88 | $2.69 |
| Average True Range (ATR) | 0.24 | 0.10 |
| MACD | -0.10 | 0.01 |
| Stochastic Oscillator | 12.66 | 57.26 |
Price Performance
Historical ComparisonAbout FUSB First US Bancshares Inc.
First US Bancshares Inc is a bank holding company. The Bank conducts general commercial banking business and offers banking services such as demand, savings, individual retirement account and time deposits, personal and commercial loans, safe deposit box services, and remote deposit capture. The Bank provides a range of commercial banking services to small and medium-sized businesses, property managers, business executives, professionals, and other individuals.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.